1 / 6

CMS Announced New Hospital Procedure Codes For Therapeutics

<br>The emergence of coronavirus disease 2019 (COVID19) and the new treatments that have followed, to track the use of treatments is critical and their effectiveness is real time. The CMS responded this need, and in record time is implementing new procedure codes to allow Medicare and other insurers to identify the use of the therapeutics remdesivir and convalescent plasma for treating hospital in-patients with COVID-19.

richardssmith
Télécharger la présentation

CMS Announced New Hospital Procedure Codes For Therapeutics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CMS Announced New Hospital Procedure Codes For Therapeutics

  2. CMS Announced New Hospital Procedure Codes For Therapeutics The emergence of coronavirus disease 2019 (COVID19) and the new treatments that have followed, to track the use of treatments is critical and their effectiveness is real time. The CMS responded this need, and in record time is implementing new procedure codes to allow Medicare and other insurers to identify the use of the therapeutics remdesivir and convalescent plasma for treating hospital in-patients with COVID-19. These new codes will be effective from August 1, and these will enable CMS to conduct real-time surveillance and obtain real-world evidence in how these drugs are working and provide critical information on their usefulness and how they can protect patients. These new codes are helpful to report to Medicare and other insurers may also use the codes to identify the use of COVID19 therapies. This also help to facilitate monitoring and data collection on their use. These new codes are being implemented into the International Classification of Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS). ICD-10-PCS is the Health Insurance Portability and Accountability Act (HIPAA) designated code set for reporting hospital inpatient procedures, which is developed and maintained by CMS and can be used by other health insurers. The implementation of these new procedure codes is part of the Trump Administration’s ongoing efforts to protect the health and safety of COVID-19 patients across the country during the public health emergency.

  3. CMS Announced New Hospital Procedure Codes For Therapeutics Assignment of the new ICD-10-PCS procedure codes is as follows: Procedure Code XW013F5 Introduction of Other New Technology Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5. Procedure Code XW033E5 Introduction of Remdesivir Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5 Procedure Code XW033F5 Introduction of Other New Technology Therapeutic Substance into Peripheral Vein, Percutaneous Approach, New Technology Group 5 Procedure Code XW033G5 Introduction of Sarilumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5 Procedure Code XW033H5 Introduction of Tocilizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5

  4. CMS Announced New Hospital Procedure Codes For Therapeutics Procedure Code XW043E5 Introduction of Remdesivir Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5 Procedure Code XW043F5 Introduction of Other New Technology Therapeutic Substance into Central Vein, Percutaneous Approach, New Technology Group 5 Procedure Code XW043G5 Introduction of Sarilumab into Central Vein, Percutaneous Approach, New Technology Group 5 Procedure Code XW043H5 Introduction of Tocilizumab into Central Vein, Percutaneous Approach, New Technology Group 5 Procedure Code XW0DXF5 Introduction of Other New Technology Therapeutic Substance into Mouth and Pharynx, External Approach, New Technology Group 5

  5. CMS Announced New Hospital Procedure Codes For Therapeutics Procedure Code XW13325 Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5 Procedure Code XW14325 Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach, New Technology Group 5 As the procedure codes are designated as non-O.R. procedures, there is no assigned MDC or MS-DRG. The ICD-10 MS-DRG assignment is dependent on the reported principal diagnosis, any secondary diagnoses defined as a complication or comorbidity (CC) or major complication or comorbidity (MCC), procedures or services performed, age, sex, and discharge status. Are You Ready To Get Billing? Want to overcome healthcare revenue cycle challenges? You are at the right place, what you need now is a partner who can finish out the rest of the work and make the technology and implementation just as simple. That’s what the best medical billing company like Medisys Data Solutions Inc can do. If you’re ready to get started, schedule a meeting with our medical billing manager from filling out enquiry form from our website!

  6. CMS Announced New Hospital Procedure Codes For Therapeutics Get more information at: The ICD-10 MS-DRG V37.2 Grouper Software, Definitions Manual Table of Contents and the Definitions of Medicare Code Edits V37.2 manual The Code Tables, Index and related Addenda files for the 12 new procedure codes

More Related